DISCOVER Publications

Bibliography

DISCOVER will provide unprecedented insights into the management of patients with type 2 diabetes mellitus globally and in each country involved. As soon as publications are available, they will be included here. Please check back regularly to keep up to date with the latest developments.

Articles

1. Ji L, Bonnet F, Charbonnel B, Gomes MB, Kosiborod M, Khunti K, Nicolucci A, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Watada H, Fenici P, Hammar N, Hashigami K, Macaraeg G, Surmont F, Medina J. Towards an improved global understanding of treatment and outcomes in people with type 2 diabetes: Rationale and methods of the DISCOVER observational study program. J Diabetes Complications 2017;31(7):1188–96.

Available from: https://doi.org/10.1016/j.jdiacomp.2017.03.011 (Accessed September 2019).

2. Khunti K, Gomes MB, Pocock S, Shestakova MV, Pintat S, Fenici P, Hammar N, Medina J. Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: a systematic review. Diabetes Obes Metab. 2018;20(2):427–437.

Available from: doi.org/10.1111/dom.13088 (Accessed September 2019).

3. Khunti K, Godec TR, Medina J, Garcia-Alvarez L, Hiller J, Gomes MB, Cid-Ruzafa J, Charbonnel B, Fenici P, Hammar N, Hashigami K, Kosiborod M, Nicolucci A, Shestakova MV, Ji L, Pocock S. Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany. Diabetes Obes Metab. 2018;20(2):389–399.

Available from: doi.org/10.1111/dom.13083 (Accessed September 2019).

4. Kosiborod M, Gomes MB, Nicolucci A, Pocock S, Rathmann W, Shestakova MV, Watada H, Shimomura I, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Surmont F, Tang F, Khunti K. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Cardiovasc. Diabetol 2018;17(1):150.

Available from: https://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0787-8 (Accessed September 2019).

5. Pintat S, Fenici P, Hammar N, Ji L, Khunti K, Medina J, Tang F, Wittbrodt E, Surmont F. Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study. BMJ Open Diabetes Res Care. 2019;7:e000627.

Available from: https://drc.bmj.com/content/7/1/e000627 (Accessed September 2019).

6. Gomes MB, Rathmann W, Charbonnel B, Khunti K, Kosiborod M, Nicolucci A, Pocock S, Shestakova MV, Shimomura I, Tang F, Watada H, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Surmont F, Ji L. Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study. Diabetes Res Clin Pract. 2019;151: 20–32.

Available from: https://doi.org/10.1016/j.diabres.2019.03.024 (Accessed September 2019).

7. Khunti K, Chen H, Cid-Ruzada J, Fenici P, Gomes MB, Hammar N, Ji L, Kosiborod M, Pocock S, Shestakova MV, Shinomura I, Tang F, Watada H, Nicolucci A. Glycaemic Control in Patients with Type 2 Diabetes Initiating Second Line Therapy: Results From the Global DISCOVER Study Programme. Diabetes Obes Metab 2019; [Epub ahead of print].

Available from: https://doi.org/10.1111/dom.13866 (Accessed September 2019).

8. Nicolucci A, Charbonnel B, Gomes MB, et al. Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme. Diabetes Obes Metab 2019; [Epub ahead of print].

Available from: https://doi.org/10.1111/dom.13830 (Accessed September 2019).

Abstracts

1. Ji L, Charbonnel B, Cook W, Fenici P, García-Sanchez R, Gomes MB, Hammar N, Hashigami K, Khunti K, Nicolucci A, Shestakova MV, Shimomura I, Surmont F, Medina J. DISCOVER – a global study program to assess real world evidence on treatment and outcomes of patients with type 2 diabetes (T2D). Published at the 75th Scientific Sessions of the American Diabetes Association, 5–9 June 2015, Boston, MA, USA.

Available from: http://app.core-apps.com/tristar_ada15/abstract/160858d53930b598d64b10f393d55b14 (Accessed September 2019).

Oral presentations

1. Kosiborod M, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Nicolucci A, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Tang F, Watada H, Khunti K. Global prevalence of type 2 diabetes complications in 14 178 patients initiating second-line therapy: the DISCOVER study. Presented at the 77th Scientific Sessions of the American Diabetes Association, 9–13 June 2017, San Diego, California, USA.

2. Arnold SV, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Khunti K, Luporini Saraiva G, Medina J, Pocock S, Sadikot S, Shestakova MV, Shimomura I, Surmont F, Tang F, Vora J, Watada H, Ji L, Charbonnel B, Bonnet F, Kosiborod M. Type 2 Diabetes and Heart Failure: Insights from the DISCOVER Study. Presented at the European Association for the Study of Diabetes annual meeting, 16–20 September, 2019, Barcelona, Spain.

Posters

1. Charbonnel B, Gomes MB, Khunti K, Nicolucci A, Pocock S, Shestakova MV, Fenici P, García-Álvarez L, Hammar N, Hashigami K, Hiller J, Medina J, Surmont F, Ji L. DISCOVERing treatment of type 2 diabetes in real world settings using electronic medical record databases. Presented at the European Association for the Study of Diabetes Annual Meeting, 14–18 September, 2015, Stockholm, Sweden.

Available from http://www.easdvirtualmeeting.org/resources/discovering-treatment-of-type-2-diabetes-in-real-world-settings-using-electronic-medical-record-databases--3 (Accessed September 2019).

2. Lindh A, Persson F, Sobocki P, Bodegård J, Lindarck N. Nordic longitudinal data from electronic records and full population national registers: unique opportunities for new insights in benefit of diabetes patients. Presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 7–11 November 2015, Milan, Italy.

3. Pocock S, Charbonnel B, Gomes MB, Khunti K, Kosiborod M, Nicolucci A, Shestakova MV, Fenici P, Hammar N, Hashigami K, Hiller J, Lillie M, Macaraeg G, Medina J, Ji L. Suboptimal glycaemic control in patients with type 2 diabetes: retrospective data from 22 272 individuals. Presented at the 76th Scientific Sessions of the American Diabetes Association, 10–14 June 2016, New Orleans, Louisiana, USA.

Available by searching 1558-P on: https://ada.scientificposters.com/ (Accessed September 2019).

4. Nicolucci A, Charbonnel B, Gomes MB, Khunti K, Kosiborod M, Pocock S, Shestakova MV, Fenici P, Hammar N, Hashigami K, Hiller J, Lillie M, Macaraeg G, Medina J, Ji L. Suboptimal glycaemic control in patients with type 2 diabetes: retrospective data from 22 272 individuals. Presented at the European Association for the Study of Diabetes Annual Meeting, 12–16 September, 2016, Munich, Germany.

Available from: http://www.easdvirtualmeeting.org/resources/suboptimal-glycaemic-control-in-patients-with-type-2-diabetes-retrospective-data-from-22-272-individuals-c0e1984e-28d3-40ee-ad7d-6e60f3ca9e9a (Accessed September 2019).

5. Harmand S, Maillard C, Thomas-Delecourt F. Étude DISCOVER France. Poster presented at Colloque des données de santé en vie réelle (local French congress) / Real Life Health Data Symposium 13 June 2017, Paris, France.

6. Nicolucci A, Arya N, Charbonnel B, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Khunti K, Kosiborod M, Shestakova MV, Shimomura I, Tang F, Watada H, Pocock S. Treatment Patterns and Associated Factors in 13 379 Patients with Type 2 Diabetes Initiating a Second-Line Therapy: The DISCOVER Study. Presented at the 77th Scientific Sessions of the American Diabetes Association, 9–13 June 2017, San Diego, California, USA.

Available by searching 1219-P on: https://ada.scientificposters.com/ (Accessed September 2019).

7. Khunti K, Arya N, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Ji L, Kosiborod M, Pocock S, Shestakova MV, Shimomura I, Tang F, Watada H, Nicolucci A. Glycaemic Control in 14 005 Patients with Type 2 Diabetes Initiating Second-Line Therapy in 36 Countries: The DISCOVER Study. Presented at the 77th Scientific Sessions of the American Diabetes Association, 9–13 June 2017, San Diego, California, USA.

Available by searching 1675-P on: https://ada.scientificposters.com/ (Accessed September 2019).

8. Shestakova MV, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Kosiborod M, Nicolucci A, Pocock S, Rathmann W, Shimomura I, Tang F, Watada H, Khunti K. Global prevalence of type 2 diabetes complications in 14 178 patients initiating second-line therapy: the DISCOVER study. Encore from ADA 2017; presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 1126 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2019).

9. Nicolucci A, Arya N, Charbonnel B, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Khunti K, Kosiborod M, Shestakova MV, Shimomura I, Tang F, Watada H, Pocock S. Treatment patterns and associated factors in 13 128 patients with type 2 diabetes initiating a second-line therapy: the DISCOVER study. Encore from ADA 2017; presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 662 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2019).

10. Ji L, Nicolucci A, Arya N, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Kosiborod M, Pocock S, Shestakova MV, Watada H, Shimomura I, Tang F, Khunti K. Glycaemic control in 13 791 patients with type 2 diabetes initiating second-line therapy in 36 countries: the DISCOVER study. Encore from ADA 2017; presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 302 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2019).

11. Khunti K, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Kosiborod M, Nicolucci A, Pocock S, Rathmann W, Shestakova MV, Watada H, Shimomura I, Tang F, Ji L. Factors associated with the discontinuation of metformin therapy: results from 11 452 patients in the global DISCOVER study. Presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 906 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2019).

12. Gomes MB, Charbonnel B, Cid-Ruzafa J, Fenici P, Hammar N, Khunti K, Kosiborod M, Nicolucci A, Pocock S, Shestakova MV, Watada H, Shimomura I, Tang F, Ji L. Glycaemic, lipid and blood pressure control according to guidelines in patients initiating second-line glucose-lowering therapy: results from the global DISCOVER study. Presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 301 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2019).

13. Rathmann W, Charbonnel B, Gomes MB, Hammar N, Khunti K, Kosiborod M, Kuss O, Shestakova MV, Watada H, Shimomura I, Tang F, Ji L. Factors associated with hypoglycaemia in 12 679 patients starting second-line therapy: the global DISCOVER study. Presented at the International Diabetes Federation congress, 4–8 December 2017, Abu Dhabi, United Arab Emirates.

Available from: https://www2.morressier.com/#/post-wvent/244/posters/77790 (Accessed September 2019).

14. Patel K, Charbonnel B, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Ji L, Kennedy K, Khunti K, Kosiborod M, Pocock S, Shestakova M, Shimomura I, Surmont F, Watada H, Gomes M. Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: insights from the global DISCOVER registry. Presented at the American Heart Association Quality of Care and Outcome Research Scientific Sessions, April 6–7 2018, Arlington, Virginia, USA.

15. Khunti K, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Kennedy K, Kosiborod M, Pocock S, Shestakova MV, Shimomura I, Surmont F, Ji L. Individualized HbA1c targets in people with type 2 diabetes initiating second-line therapy: the global DISCOVER study. Presented at the American Diabetes Association’s 78th Scientific Sessions, June 22–26 2018, Orlando, Florida, USA.

Available by searching 1629-P on: https://ada.scientificposters.com/ (Accessed September 2019).

16. Charbonnel B, Bonnet F, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Ji L, Kennedy K, Rathmann W, Kosiborod M, Pocock S, Shestakova MV, Shimomura I, Surmont F, Khunti K. Change over 12 months in HbA1c, fasting plasma glucose and weight among patients with type 2 diabetes in 37 countries: DISCOVER. Presented at the American Diabetes Association’s 78th Scientific Sessions, June 22–26 2018, Orlando, Florida, USA.

Available by searching 1615-P on: https://ada.scientificposters.com/ (Accessed September 2019).

17. Kosiborod M, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Khunti K, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Surmont F, Tang F, Watada H, Ji L, Hammar N. Vascular events in patients with type 2 diabetes in the year following initiation of second-line therapy: the DISCOVER study. Presented at the American Diabetes Association’s 78th Scientific Sessions, June 22–26 2018, Orlando, Florida, USA.

Available by searching 1528-P on: https://ada.scientificposters.com/ (Accessed September 2019).

18. Kosiborod M, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Khunti K, Pocock S, Shestakova MV, Shimomura I, Surmont F, Tang F, Ji L. Temporal trends in the use of sodium-glucose co-transporter-2 inhibitors: the global DISCOVER study. Presented at the American Diabetes Association’s 78th Scientific Sessions, June 22–26 2018, Orlando, Florida, USA.

Available by searching 1141-P on: https://ada.scientificposters.com/ (Accessed September 2019).

19. Rathmann W, Medina J, Kosiborod M, Nicolucci A, Cid-Ruzafa J, Fenici P, Hammar N, Surmont F, Khunti K. The DISCOVER study: diversity of sites, physicians and patients. Presented at the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 22–26 August 2018, Prague, Czech Republic.

20. Gomes MB, Patel KB, Charbonnel B, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Ji L, Kennedy KF, Pocock S, Shestakova MV, Shimomura I, Watada H. Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: insights from the global DISCOVER study program. Presented at the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD), 1–5 October 2018, Berlin, Germany.

Available by searching 854 on https://www.easd.org/virtualmeeting/home.html#!resourcegroups/order=primary_event_starts_at&event_ids=13&page=1&group=&resourcetype_ids=&tag_ids= (Accessed September 2019).

21. Surmont F, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Khunti K, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Tang F, Watada H, Ji L, Hammar N, Kosiborod M. Vascular events in patients with type 2 diabetes in the year following initiation of second-line therapy: the DISCOVER study. Presented at the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD), 1–5 October 2018, Berlin, Germany.

Available by searching 1150 on https://www.easd.org/virtualmeeting/home.html#!resourcegroups/order=primary_event_starts_at&event_ids=13&page=1&group=&resourcetype_ids=&tag_ids= (Accessed September 2019).

22. Fenici P, Bonnet F, Chen H, Cid-Ruzafa J, Gomes MB, Hammar N, Ji L, Kennedy KF, Khunti K, Kosiborod M, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Charbonnel B. Change over 12 months in HbA1c, fasting plasma glucose and weight among patients with type 2 diabetes in 37 countries: DISCOVER. Presented at the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD), 1–5 October 2018, Berlin, Germany.

Available by searching 294 on https://www.easd.org/virtualmeeting/home.html#!resourcegroups/order=primary_event_starts_at&event_ids=13&page=1&group=&resourcetype_ids=&tag_ids= (Accessed September 2019).

23.Nicolucci A, Gomes MB, Khunti K, Kosiborod M, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Watada H, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Tang F, Ji L. Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: the global DISCOVER study. Presented at the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD), 1–5 October 2018, Berlin, Germany.

Available by searching 344 on https://www.easd.org/virtualmeeting/home.html#!resourcegroups/order=primary_event_starts_at&event_ids=13&page=1&group=&resourcetype_ids=&tag_ids= (Accessed September 2019).

24. Khunti K, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Kennedy KF, Pocock S, Shestakova MV, Shimomura I, Surmont F, Ji L. Individualized HbA1c targets in people with type 2 diabetes initiating second-line therapy: the global DISCOVER study. Presented at the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD), 1–5 October 2018, Berlin, Germany.

Available by searching 347 on https://www.easd.org/virtualmeeting/home.html#!resourcegroups/order=primary_event_starts_at&event_ids=13&page=1&group=&resourcetype_ids=&tag_ids= (Accessed September 2019).

25. Ji L, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Khunti K, Pocock S, Shestakova MV, Shimomura I, Surmont F, Tang F, Kosiborod M. Temporal trends in the use of sodium-glucose cotransporter-2 inhibitors: the global DISCOVER study. Presented at the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD), 1–5 October 2018, Berlin, Germany.

Available by searching 638 on https://www.easd.org/virtualmeeting/home.html#!resourcegroups/order=primary_event_starts_at&event_ids=13&page=1&group=&resourcetype_ids=&tag_ids= (Accessed September 2019).

26. Bongaerts B, Arnold SV, Charbonnel B, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Ji L, Khunti K, Kosiborod M, Luporini Saraiva G, Medina J, Nicolucci A, Pocock S, Sadikot S, Shestakova MV, Shimomura I, Surmont F, Tang F, Watada H, Rathmann W. Potential overtreatment of older patients with type 2 diabetes: the global DISCOVER study. Presented at the American Diabetes Association’s 79th Scientific Sessions, 7–11 June 2019 in San Francisco, California, USA.

Available by searching 1448-P on https://ada.scientificposters.com/epsSearchADA.cfm (Accessed September 2019).

27. Gomes MB, Tang F, Chen H, Cid-Ruzafa J, Fenici P, Khunti K, Pocock S, Rathmann W, Shestakova MV, Surmont F, Watada H, Medina J, Sadikot S, Shimomura I, Luporini Saraiva G, Nicolucci A. Socioeconomic factors associated with poor glycaemic control (HbA1c level ≥ 9.0%) in people with type 2 diabetes: the DISCOVER study program. Presented at the American Diabetes Association’s 79th Scientific Sessions, 7–11 June 2019 in San Francisco, California, USA.

Available by searching 1279-P on https://ada.scientificposters.com/epsSearchADA.cfm (Accessed September 2019).

28. Charbonnel B, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Luporini Saraiva G, Medina J, Nicolucci A, Pocock S, Shestakova MV, Shimomura I, Sadikot S, Surmont F, Tang F, Vora J, Watada H, Khunti K. Changes in HbA1c levels and treatment in the second year following initiation of second-line therapy in people with type 2 diabetes: the global DISCOVER study. Presented at the American Diabetes Association’s 79th Scientific Sessions, 7–11 June 2019 in San Francisco, California, USA.

Available by searching 1628-P on https://ada.scientificposters.com/epsSearchADA.cfm (Accessed September 2019).

29. Arnold SV, Chen H, Cid-Ruzafa J, Fenici P, Gomes MG, Khunti K, Luporini Saraiva G, Medina J, Shestakova MV, Shimomura I, Surmont F, Tang F, Vora J, Watada H, Kosiborod M. Microvascular and macrovascular events in patients with T2D: results from the global DISCOVER study. Presented at the American Diabetes Association’s 79th Scientific Sessions, 7–11 June 2019 in San Francisco, California, USA.

Available by searching 420-P on https://ada.scientificposters.com/epsSearchADA.cfm (Accessed September 2019).

30. Arnold SV, Chen H, Cid-Ruzafa J, Fenici P, Gomes MG, Khunti K, Luporini Saraiva G, Medina J, Pocock S, Sadikot S, Shestakova MV, Shimomura I, Surmont F, Tang F, Vora J, Watada H, Ji L, Charbonnel B, Bonnet F, Kosiborod M. Type 2 diabetes and heart failure: insights from the DISCOVER study. Presented at the American Diabetes Association’s 79th Scientific Sessions, 7–11 June 2019 in San Francisco, California, USA.

Available by searching 207-LB on https://ada.scientificposters.com/epsSearchADA.cfm (Accessed September 2019)

31. Khunti K, Charbonnel B, Cherney DZ, Gomes MB, Heerspink HJL, Ji L, Medina J, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Tang F, Watada H, Kosiborod M, Arnold SV. Type 2 diabetes and chronic kidney disease: insights from DISCOVER. Presented at the European Association for the Study of Diabetes annual meeting, 16–20 September, 2019, Barcelona, Spain.

Available by searching 1008 on https://www.easd.org/virtualmeeting/home.html#!resourcegroups (Accessed September 2019).

32. Gomes MB, Tang F, Chen H, Cid-Ruzafa J, Fenici P, Khunti K, Pocock S, Rathmann W, Shestakova MV, Surmont F, Watada H, Medina J, Shimomura I, Luporini Saraiva G, Nicolucci A. Socioeconomic factors associated with poor glycaemic control (HbA1c ≥ 9.0%) in people with type 2 diabetes: the DISCOVER study programme. Presented at the European Association for the Study of Diabetes annual meeting, 16–20 September, 2019, Barcelona, Spain.

Available by searching 815 on https://www.easd.org/virtualmeeting/home.html#!resourcegroups (Accessed September 2019).

33. Nicolucci A, Chen H, Fenici P, Gomes MB, Luporini Saraiva G, Medina J, Pocock S, Shestakova MV, Shimomura I, Surmont F, Tang F, Vora J, Watada H, Khunti K, Charbonnel B. Changes in HbA1c levels and treatment in the second year following initiation of second-line therapy in people with type 2 diabetes: the global DISCOVER study. Presented at the European Association for the Study of Diabetes annual meeting, 16–20 September, 2019, Barcelona, Spain.

Available by searching 353 on https://www.easd.org/virtualmeeting/home.html#!resourcegroups (Accessed September 2019).

 

  • Veeva ID: Z4-20322
  • Date of preparation: October 2019
  • Date of expiry: October 2020

 

Abstracts

1. Ji L, Charbonnel B, Cook W, Fenici P, García-Sanchez R, Gomes MB, Hammar N, Hashigami K, Khunti K, Nicolucci A, Shestakova MV, Shimomura I, Surmont F, Medina J. DISCOVER – a global study program to assess real world evidence on treatment and outcomes of patients with type 2 diabetes (T2D). Published at the 75th Scientific Sessions of the American Diabetes Association, 5–9 June 2015, Boston, MA, USA.

Available from: http://app.core-apps.com/tristar_ada15/abstract/160858d53930b598d64b10f393d55b14 (Accessed September 2019).

Posters

1. Charbonnel B, Gomes MB, Khunti K, Nicolucci A, Pocock S, Shestakova MV, Fenici P, García-Álvarez L, Hammar N, Hashigami K, Hiller J, Medina J, Surmont F, Ji L. DISCOVERing treatment of type 2 diabetes in real world settings using electronic medical record databases. Presented at the European Association for the Study of Diabetes Annual Meeting, 14–18 September, 2015, Stockholm, Sweden.

Available from http://www.easdvirtualmeeting.org/resources/discovering-treatment-of-type-2-diabetes-in-real-world-settings-using-electronic-medical-record-databases--3 (Accessed September 2019).

2. Lindh A, Persson F, Sobocki P, Bodegård J, Lindarck N. Nordic longitudinal data from electronic records and full population national registers: unique opportunities for new insights in benefit of diabetes patients. Presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 7–11 November 2015, Milan, Italy.

3. Pocock S, Charbonnel B, Gomes MB, Khunti K, Kosiborod M, Nicolucci A, Shestakova MV, Fenici P, Hammar N, Hashigami K, Hiller J, Lillie M, Macaraeg G, Medina J, Ji L. Suboptimal glycaemic control in patients with type 2 diabetes: retrospective data from 22 272 individuals. Presented at the 76th Scientific Sessions of the American Diabetes Association, 10–14 June 2016, New Orleans, Louisiana, USA.

Available by searching 1558-P on: https://ada.scientificposters.com/ (Accessed September 2019).

4. Nicolucci A, Charbonnel B, Gomes MB, Khunti K, Kosiborod M, Pocock S, Shestakova MV, Fenici P, Hammar N, Hashigami K, Hiller J, Lillie M, Macaraeg G, Medina J, Ji L. Suboptimal glycaemic control in patients with type 2 diabetes: retrospective data from 22 272 individuals. Presented at the European Association for the Study of Diabetes Annual Meeting, 12–16 September, 2016, Munich, Germany.

Available from: http://www.easdvirtualmeeting.org/resources/suboptimal-glycaemic-control-in-patients-with-type-2-diabetes-retrospective-data-from-22-272-individuals-c0e1984e-28d3-40ee-ad7d-6e60f3ca9e9a (Accessed September 2019).

5. Harmand S, Maillard C, Thomas-Delecourt F. Étude DISCOVER France. Poster presented at Colloque des données de santé en vie réelle (local French congress) / Real Life Health Data Symposium 13 June 2017, Paris, France.

6. Nicolucci A, Arya N, Charbonnel B, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Khunti K, Kosiborod M, Shestakova MV, Shimomura I, Tang F, Watada H, Pocock S. Treatment Patterns and Associated Factors in 13 379 Patients with Type 2 Diabetes Initiating a Second-Line Therapy: The DISCOVER Study. Presented at the 77th Scientific Sessions of the American Diabetes Association, 9–13 June 2017, San Diego, California, USA.

Available by searching 1219-P on: https://ada.scientificposters.com/ (Accessed September 2019).

7. Khunti K, Arya N, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Ji L, Kosiborod M, Pocock S, Shestakova MV, Shimomura I, Tang F, Watada H, Nicolucci A. Glycaemic Control in 14 005 Patients with Type 2 Diabetes Initiating Second-Line Therapy in 36 Countries: The DISCOVER Study. Presented at the 77th Scientific Sessions of the American Diabetes Association, 9–13 June 2017, San Diego, California, USA.

Available by searching 1675-P on: https://ada.scientificposters.com/ (Accessed September 2019).

8. Shestakova MV, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Kosiborod M, Nicolucci A, Pocock S, Rathmann W, Shimomura I, Tang F, Watada H, Khunti K. Global prevalence of type 2 diabetes complications in 14 178 patients initiating second-line therapy: the DISCOVER study. Encore from ADA 2017; presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 1126 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2019).

9. Nicolucci A, Arya N, Charbonnel B, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Khunti K, Kosiborod M, Shestakova MV, Shimomura I, Tang F, Watada H, Pocock S. Treatment patterns and associated factors in 13 128 patients with type 2 diabetes initiating a second-line therapy: the DISCOVER study. Encore from ADA 2017; presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 662 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2019).

10. Ji L, Nicolucci A, Arya N, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Kosiborod M, Pocock S, Shestakova MV, Watada H, Shimomura I, Tang F, Khunti K. Glycaemic control in 13 791 patients with type 2 diabetes initiating second-line therapy in 36 countries: the DISCOVER study. Encore from ADA 2017; presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 302 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2019).

11. Khunti K, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Kosiborod M, Nicolucci A, Pocock S, Rathmann W, Shestakova MV, Watada H, Shimomura I, Tang F, Ji L. Factors associated with the discontinuation of metformin therapy: results from 11 452 patients in the global DISCOVER study. Presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 906 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2019).

12. Gomes MB, Charbonnel B, Cid-Ruzafa J, Fenici P, Hammar N, Khunti K, Kosiborod M, Nicolucci A, Pocock S, Shestakova MV, Watada H, Shimomura I, Tang F, Ji L. Glycaemic, lipid and blood pressure control according to guidelines in patients initiating second-line glucose-lowering therapy: results from the global DISCOVER study. Presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 301 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2019).

13. Rathmann W, Charbonnel B, Gomes MB, Hammar N, Khunti K, Kosiborod M, Kuss O, Shestakova MV, Watada H, Shimomura I, Tang F, Ji L. Factors associated with hypoglycaemia in 12 679 patients starting second-line therapy: the global DISCOVER study. Presented at the International Diabetes Federation congress, 4–8 December 2017, Abu Dhabi, United Arab Emirates.

Available from: https://www2.morressier.com/#/post-wvent/244/posters/77790 (Accessed September 2019).

14. Patel K, Charbonnel B, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Ji L, Kennedy K, Khunti K, Kosiborod M, Pocock S, Shestakova M, Shimomura I, Surmont F, Watada H, Gomes M. Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: insights from the global DISCOVER registry. Presented at the American Heart Association Quality of Care and Outcome Research Scientific Sessions, April 6–7 2018, Arlington, Virginia, USA.

15. Khunti K, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Kennedy K, Kosiborod M, Pocock S, Shestakova MV, Shimomura I, Surmont F, Ji L. Individualized HbA1c targets in people with type 2 diabetes initiating second-line therapy: the global DISCOVER study. Presented at the American Diabetes Association’s 78th Scientific Sessions, June 22–26 2018, Orlando, Florida, USA.

Available by searching 1629-P on: https://ada.scientificposters.com/ (Accessed September 2019).

16. Charbonnel B, Bonnet F, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Ji L, Kennedy K, Rathmann W, Kosiborod M, Pocock S, Shestakova MV, Shimomura I, Surmont F, Khunti K. Change over 12 months in HbA1c, fasting plasma glucose and weight among patients with type 2 diabetes in 37 countries: DISCOVER. Presented at the American Diabetes Association’s 78th Scientific Sessions, June 22–26 2018, Orlando, Florida, USA.

Available by searching 1615-P on: https://ada.scientificposters.com/ (Accessed September 2019).

17. Kosiborod M, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Khunti K, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Surmont F, Tang F, Watada H, Ji L, Hammar N. Vascular events in patients with type 2 diabetes in the year following initiation of second-line therapy: the DISCOVER study. Presented at the American Diabetes Association’s 78th Scientific Sessions, June 22–26 2018, Orlando, Florida, USA.

Available by searching 1528-P on: https://ada.scientificposters.com/ (Accessed September 2019).

18. Kosiborod M, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Khunti K, Pocock S, Shestakova MV, Shimomura I, Surmont F, Tang F, Ji L. Temporal trends in the use of sodium-glucose co-transporter-2 inhibitors: the global DISCOVER study. Presented at the American Diabetes Association’s 78th Scientific Sessions, June 22–26 2018, Orlando, Florida, USA.

Available by searching 1141-P on: https://ada.scientificposters.com/ (Accessed September 2019).

19. Rathmann W, Medina J, Kosiborod M, Nicolucci A, Cid-Ruzafa J, Fenici P, Hammar N, Surmont F, Khunti K. The DISCOVER study: diversity of sites, physicians and patients. Presented at the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 22–26 August 2018, Prague, Czech Republic.

20. Gomes MB, Patel KB, Charbonnel B, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Ji L, Kennedy KF, Pocock S, Shestakova MV, Shimomura I, Watada H. Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: insights from the global DISCOVER study program. Presented at the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD), 1–5 October 2018, Berlin, Germany.

Available by searching 854 on https://www.easd.org/virtualmeeting/home.html#!resourcegroups/order=primary_event_starts_at&event_ids=13&page=1&group=&resourcetype_ids=&tag_ids= (Accessed September 2019).

21. Surmont F, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Khunti K, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Tang F, Watada H, Ji L, Hammar N, Kosiborod M. Vascular events in patients with type 2 diabetes in the year following initiation of second-line therapy: the DISCOVER study. Presented at the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD), 1–5 October 2018, Berlin, Germany.

Available by searching 1150 on https://www.easd.org/virtualmeeting/home.html#!resourcegroups/order=primary_event_starts_at&event_ids=13&page=1&group=&resourcetype_ids=&tag_ids= (Accessed September 2019).

22. Fenici P, Bonnet F, Chen H, Cid-Ruzafa J, Gomes MB, Hammar N, Ji L, Kennedy KF, Khunti K, Kosiborod M, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Charbonnel B. Change over 12 months in HbA1c, fasting plasma glucose and weight among patients with type 2 diabetes in 37 countries: DISCOVER. Presented at the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD), 1–5 October 2018, Berlin, Germany.

Available by searching 294 on https://www.easd.org/virtualmeeting/home.html#!resourcegroups/order=primary_event_starts_at&event_ids=13&page=1&group=&resourcetype_ids=&tag_ids= (Accessed September 2019).

23.Nicolucci A, Gomes MB, Khunti K, Kosiborod M, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Watada H, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Tang F, Ji L. Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: the global DISCOVER study. Presented at the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD), 1–5 October 2018, Berlin, Germany.

Available by searching 344 on https://www.easd.org/virtualmeeting/home.html#!resourcegroups/order=primary_event_starts_at&event_ids=13&page=1&group=&resourcetype_ids=&tag_ids= (Accessed September 2019).

24. Khunti K, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Kennedy KF, Pocock S, Shestakova MV, Shimomura I, Surmont F, Ji L. Individualized HbA1c targets in people with type 2 diabetes initiating second-line therapy: the global DISCOVER study. Presented at the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD), 1–5 October 2018, Berlin, Germany.

Available by searching 347 on https://www.easd.org/virtualmeeting/home.html#!resourcegroups/order=primary_event_starts_at&event_ids=13&page=1&group=&resourcetype_ids=&tag_ids= (Accessed September 2019).

25. Ji L, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Khunti K, Pocock S, Shestakova MV, Shimomura I, Surmont F, Tang F, Kosiborod M. Temporal trends in the use of sodium-glucose cotransporter-2 inhibitors: the global DISCOVER study. Presented at the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD), 1–5 October 2018, Berlin, Germany.

Available by searching 638 on https://www.easd.org/virtualmeeting/home.html#!resourcegroups/order=primary_event_starts_at&event_ids=13&page=1&group=&resourcetype_ids=&tag_ids= (Accessed September 2019).

26. Bongaerts B, Arnold SV, Charbonnel B, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Ji L, Khunti K, Kosiborod M, Luporini Saraiva G, Medina J, Nicolucci A, Pocock S, Sadikot S, Shestakova MV, Shimomura I, Surmont F, Tang F, Watada H, Rathmann W. Potential overtreatment of older patients with type 2 diabetes: the global DISCOVER study. Presented at the American Diabetes Association’s 79th Scientific Sessions, 7–11 June 2019 in San Francisco, California, USA.

Available by searching 1448-P on https://ada.scientificposters.com/epsSearchADA.cfm (Accessed September 2019).

27. Gomes MB, Tang F, Chen H, Cid-Ruzafa J, Fenici P, Khunti K, Pocock S, Rathmann W, Shestakova MV, Surmont F, Watada H, Medina J, Sadikot S, Shimomura I, Luporini Saraiva G, Nicolucci A. Socioeconomic factors associated with poor glycaemic control (HbA1c level ≥ 9.0%) in people with type 2 diabetes: the DISCOVER study program. Presented at the American Diabetes Association’s 79th Scientific Sessions, 7–11 June 2019 in San Francisco, California, USA.

Available by searching 1279-P on https://ada.scientificposters.com/epsSearchADA.cfm (Accessed September 2019).

28. Charbonnel B, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Luporini Saraiva G, Medina J, Nicolucci A, Pocock S, Shestakova MV, Shimomura I, Sadikot S, Surmont F, Tang F, Vora J, Watada H, Khunti K. Changes in HbA1c levels and treatment in the second year following initiation of second-line therapy in people with type 2 diabetes: the global DISCOVER study. Presented at the American Diabetes Association’s 79th Scientific Sessions, 7–11 June 2019 in San Francisco, California, USA.

Available by searching 1628-P on https://ada.scientificposters.com/epsSearchADA.cfm (Accessed September 2019).

29. Arnold SV, Chen H, Cid-Ruzafa J, Fenici P, Gomes MG, Khunti K, Luporini Saraiva G, Medina J, Shestakova MV, Shimomura I, Surmont F, Tang F, Vora J, Watada H, Kosiborod M. Microvascular and macrovascular events in patients with T2D: results from the global DISCOVER study. Presented at the American Diabetes Association’s 79th Scientific Sessions, 7–11 June 2019 in San Francisco, California, USA.

Available by searching 420-P on https://ada.scientificposters.com/epsSearchADA.cfm (Accessed September 2019).

30. Arnold SV, Chen H, Cid-Ruzafa J, Fenici P, Gomes MG, Khunti K, Luporini Saraiva G, Medina J, Pocock S, Sadikot S, Shestakova MV, Shimomura I, Surmont F, Tang F, Vora J, Watada H, Ji L, Charbonnel B, Bonnet F, Kosiborod M. Type 2 diabetes and heart failure: insights from the DISCOVER study. Presented at the American Diabetes Association’s 79th Scientific Sessions, 7–11 June 2019 in San Francisco, California, USA.

Available by searching 207-LB on https://ada.scientificposters.com/epsSearchADA.cfm (Accessed September 2019)

31. Khunti K, Charbonnel B, Cherney DZ, Gomes MB, Heerspink HJL, Ji L, Medina J, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Tang F, Watada H, Kosiborod M, Arnold SV. Type 2 diabetes and chronic kidney disease: insights from DISCOVER. Presented at the European Association for the Study of Diabetes annual meeting, 16–20 September, 2019, Barcelona, Spain.

Available by searching 1008 on https://www.easd.org/virtualmeeting/home.html#!resourcegroups (Accessed September 2019).

32. Gomes MB, Tang F, Chen H, Cid-Ruzafa J, Fenici P, Khunti K, Pocock S, Rathmann W, Shestakova MV, Surmont F, Watada H, Medina J, Shimomura I, Luporini Saraiva G, Nicolucci A. Socioeconomic factors associated with poor glycaemic control (HbA1c ≥ 9.0%) in people with type 2 diabetes: the DISCOVER study programme. Presented at the European Association for the Study of Diabetes annual meeting, 16–20 September, 2019, Barcelona, Spain.

Available by searching 815 on https://www.easd.org/virtualmeeting/home.html#!resourcegroups (Accessed September 2019).

33. Nicolucci A, Chen H, Fenici P, Gomes MB, Luporini Saraiva G, Medina J, Pocock S, Shestakova MV, Shimomura I, Surmont F, Tang F, Vora J, Watada H, Khunti K, Charbonnel B. Changes in HbA1c levels and treatment in the second year following initiation of second-line therapy in people with type 2 diabetes: the global DISCOVER study. Presented at the European Association for the Study of Diabetes annual meeting, 16–20 September, 2019, Barcelona, Spain.

Available by searching 353 on https://www.easd.org/virtualmeeting/home.html#!resourcegroups (Accessed September 2019).

 

  • Veeva ID: Z4-20322
  • Date of preparation: October 2019
  • Date of expiry: October 2020